A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T<sub>H</sub>1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study.

Rebucci-Peixoto, Magali; Vienot, Angélique; Adotevi, Olivier; Jacquin, Marion; Ghiringhelli, Francois; de la Fouchardière, Christelle; You, Benoit; Maurina, Tristan; Kalbacher, Elsa; Bazan, Fernando; Meynard, Guillaume; Clairet, Anne-Laure; Fagnoni-Legat, Christine; Spehner, Laurie; Bouard, Adeline; Vernerey, Dewi; Meurisse, Aurélia; Kim, Stefano; Borg, Christophe; Mansi, Laura

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T_H1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study.

Rebucci-Peixoto, Magali; Vienot, Angélique; Adotevi, Olivier; Jacquin, Marion; Ghiringhelli, Francois; de la Fouchardière, Christelle; You, Benoit; Maurina, Tristan; Kalbacher, Elsa; Bazan, Fernando; Meynard, Guillaume; Clairet, Anne-Laure; Fagnoni-Legat, Christine; Spehner, Laurie; Bouard, Adeline; Vernerey, Dewi; Meurisse, Aurélia; Kim, Stefano; Borg, Christophe; Mansi, Laura.

Rebucci-Peixoto M; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Vienot A; Clinical Investigational Center, CIC-1431, Centre Hospitalier Universitaire, Besançon, France.
Adotevi O; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Jacquin M; Clinical Investigational Center, CIC-1431, Centre Hospitalier Universitaire, Besançon, France.
Ghiringhelli F; INSERM, EFS BFC, UMR1098 RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
de la Fouchardière C; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
You B; Clinical Investigational Center, CIC-1431, Centre Hospitalier Universitaire, Besançon, France.
Maurina T; INSERM, EFS BFC, UMR1098 RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
Kalbacher E; Clinical Investigational Center, CIC-1431, Centre Hospitalier Universitaire, Besançon, France.
Bazan F; Cancéropôle Est, Strasbourg, France.
Meynard G; Department of Oncology, Centre Georges-François Leclerc, Dijon, France.
Clairet AL; Department of Oncology, Centre Léon Bérard, Lyon, France.
Fagnoni-Legat C; Department of Oncology, Hospices Civils de Lyon, Lyon, France.
Spehner L; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Bouard A; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Vernerey D; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Meurisse A; Department of Oncology, Centre Hospitalier Universitaire, Besançon, France.
Kim S; Department of Pharmacy, University Hospital of Besançon, Besançon, France.
Borg C; Department of Pharmacy, University Hospital of Besançon, Besançon, France.
Mansi L; INSERM, EFS BFC, UMR1098 RIGHT, University of Bourgogne Franche-Comté, Besançon, France.